In this episode, Michelle D. Collins-Ogle, MD, FAAP, FPIDS, AAHIVS, explores key considerations for choosing antiretroviral therapy (ART) for pediatric patients.Listen as she gives perspectives on:Department of Health and Human Services (DHHS) guideline recommendations for infants at risk for perinatal HIV transmissionDHHS guideline–recommended ART regimens for childrenThe ODYSSEY A and B studies evaluating dolutegravir-based ART in children and adolescentsData for the use of the fixed-dose combination bictegravir/emtricitabine/tenofovir alafenamide in children and adolescentsKey ART and management considerations for adolescents and young adults with HIVPresenter:Michelle D. Collins-Ogle, MD, FAAP, FPIDS, AAHIVSAssistant Professor of PediatricsDivision of Pediatric Infectious DiseasesPediatric and Adolescent HIV Children’s Hospital at MontefiorePediatric Hospital of Albert Einstein College of MedicineBronx, New York Follow along with the slides at:https://bit.ly/3wMur29Link to full program:https://bit.ly/3fOl0XX Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related